Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study - Quiz - MDSpire

Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study

  • By

  • Fredy Kahkedjian

  • Jaffer Shah

  • Firas Kreidieh

  • July 1, 2026

  • 0 min

Share

Original Source(s)

Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study

  • by Fredy Kahkedjian, Jaffer Shah, Firas Kreidieh

  • July 1, 2026

Related Content

Reduced circulating mitochondrial DNA integrity and increased DNA oxidation in preclinical and clinical pediatric obesity: an observational study

Innovative models to explore hepatic involvement in Prader-Willi syndrome

The liver-brain axis, from its function to preventive therapeutic strategies in diseases